Analyst Ratings for CytomX Therapeutics (CTMX) [Sells]

CTMX Rating Summary

CTMX Price Target Summary

* Over Last 12-Mos
  |   Expand Research on CTMX
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $11.92 (+78.4%) * Over Last 12-Mos
Rating Score: 7.5 / 10   Percentile Rank: 78%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
5/28/2021 Barclays Peter Lawson Downgrade Underweight
(Equalweight)
7.00
(9.00)
8.22
(6.68)
-18.73% Details
Like CTMX Ratings? Also take a look at R, CLNY, HBB, INCY

CTMX Ratings News